COSMOS Pharmaceutical Corp. (CSMYF)
40.45
+3.39
(+9.15%)
USD |
OTCM |
Sep 23, 16:00
COSMOS Pharmaceutical Accounts Receivable (Quarterly) : 5.584M for May 31, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 5.584M |
| February 28, 2026 | 5.130M |
| November 30, 2025 | 5.191M |
| August 31, 2025 | 5.244M |
| May 31, 2025 | 5.274M |
| February 28, 2025 | 4.459M |
| November 30, 2024 | 4.548M |
| August 31, 2024 | 4.519M |
| May 31, 2024 | 4.054M |
| February 29, 2024 | 3.788M |
| November 30, 2023 | 3.517M |
| August 31, 2023 | 3.386M |
| May 31, 2023 | 3.235M |
| February 28, 2023 | 2.496M |
| November 30, 2022 | 2.487M |
| August 31, 2022 | 1.933M |
| May 31, 2022 | 1.539M |
| February 28, 2022 | 1.198M |
| November 30, 2021 | 1.066M |
| August 31, 2021 | 0.7373M |
| May 31, 2021 | 0.9141M |
| February 28, 2021 | 0.8072M |
| November 30, 2020 | 0.748M |
| August 31, 2020 | 0.7638M |
| May 31, 2020 | 1.002M |
| Date | Value |
|---|---|
| February 29, 2020 | 1.956M |
| November 30, 2019 | 3.698M |
| August 31, 2019 | 2.280M |
| May 31, 2019 | 3.666M |
| February 28, 2019 | 2.65M |
| November 30, 2018 | 1.462M |
| August 31, 2018 | 0.6042M |
| May 31, 2018 | 0.8376M |
| February 28, 2018 | 0.1874M |
| November 30, 2017 | 0.2234M |
| August 31, 2017 | 0.209M |
| May 31, 2017 | 0.1989M |
| February 28, 2017 | 0.3128M |
| November 30, 2016 | 0.3159M |
| August 31, 2016 | 0.3964M |
| May 31, 2016 | 0.2525M |
| February 29, 2016 | 0.2569M |
| November 30, 2015 | 0.2515M |
| August 31, 2015 | 0.2228M |
| May 31, 2015 | 0.2015M |
| February 28, 2015 | 0.1506M |
| November 30, 2014 | 0.1517M |
| August 31, 2014 | 0.1636M |
| May 31, 2014 | 0.1671M |
| February 28, 2014 | 0.1568M |
Accounts Receivable Definition
Represents change in working capital due to increase or decrease in receivables for the given period.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Sundrug Co., Ltd. | 181.97M |
| TSURUHA Holdings, Inc. | 882.66M |
| Sugi Holdings Co., Ltd. | 515.99M |
| MatsukiyoCocokara & Co. | 430.14M |
| Ain Holdings, Inc. | 184.56M |